Vontobel Holding’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.65M Buy
6,409
+1,266
+25% +$327K 0.01% 486
2025
Q1
$1.15M Buy
5,143
+1,707
+50% +$382K ﹤0.01% 547
2024
Q4
$786K Sell
3,436
-226
-6% -$51.7K ﹤0.01% 661
2024
Q3
$894K Buy
3,662
+288
+9% +$70.3K ﹤0.01% 618
2024
Q2
$646K Sell
3,374
-10,460
-76% -$2M ﹤0.01% 700
2024
Q1
$2.74M Sell
13,834
-6,173
-31% -$1.22M 0.02% 392
2023
Q4
$3.44M Buy
20,007
+2,250
+13% +$387K 0.03% 354
2023
Q3
$2.63M Buy
17,757
+1,126
+7% +$167K 0.02% 382
2023
Q2
$3.63M Buy
16,631
+1,114
+7% +$243K 0.03% 352
2023
Q1
$3.4M Sell
15,517
-1,637
-10% -$358K 0.03% 345
2022
Q4
$3.53M Buy
17,154
+4,227
+33% +$870K 0.04% 339
2022
Q3
$2.82M Buy
12,927
+1,642
+15% +$359K 0.03% 346
2022
Q2
$2.4M Buy
11,285
+3,173
+39% +$676K 0.03% 363
2022
Q1
$2.02M Buy
8,112
+1,025
+14% +$255K 0.02% 425
2021
Q4
$1.86M Buy
7,087
+840
+13% +$220K 0.02% 458
2021
Q3
$1.65M Sell
6,247
-2,233
-26% -$588K 0.01% 486
2021
Q2
$2.09M Sell
8,480
-1,669
-16% -$411K 0.02% 423
2021
Q1
$1.97M Buy
10,149
+1,985
+24% +$385K 0.01% 403
2020
Q4
$1.65M Buy
+8,164
New +$1.65M 0.01% 406